Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trials
Health Canada issues "No Objection" letter for cancer phase I clinical trial
March 9th, 2006
Ecopia BioSciences announced that it has received a No Objection letter from the Therapeutics Products directorate of Health Canada for the commencement of a phase I clinical trial relating to the company's anticancer agent, ECO-4601. Ecopia is proposing to conduct a phase I clinical trial with up to 30 patients who will be recruited at the Clinical Research Unit of the Sir Mortimer B. Davis - Jewish General Hospital (JGH), a McGill University teaching hospital. Dr. Gerald Batist will chair the trial and Dr. Petr Kavan will be the principal investigator. Batist chairs the department of oncology of the faculty of medicine of McGill University and is the scientific...
Source: Women's Health Weekly (2006-03-09)
|
